Day: July 8, 2025

ATHENS, Greece, July 08, 2025 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK), today announced that it will release its results for the second quarter ended June 30, 2025, after the market closes in New York on Wednesday, August 6, 2025. Star Bulk’s management team will host a conference call to discuss the Company’s financial results on Thursday, August 7, 2025, at 11:00 a.m. Eastern Time (ET). Conference Call details: Participants should dial into the call 10 minutes before the scheduled time using the following numbers: (+1) 416 764 8646 / (+1) 888 396 8049. Please quote “Star Bulk Carriers” to the operator and/or conference ID 13754842. Slides and audio webcast: There will also be a live, and then archived, webcast of the conference call and accompanying...

TYSONS, Va., July 08, 2025 (GLOBE NEWSWIRE) — TEGNA Inc. (NYSE: TGNA) will host a conference call to discuss its second quarter 2025 earnings results on Thursday, August 7, 2025, at 11 a.m. (ET). The conference call will be webcast through the company’s website, and is open to investors, the financial community, the media and other members of the public. To access the meeting by phone, please visit investors.TEGNA.com at least 10 minutes prior to the scheduled start time to access the links and register before the conference call begins. Once registered, phone participants will receive dial-in numbers and a unique PIN to seamlessly access the call. TEGNA’s earnings announcement will be released to news outlets and wire services before the market opens on August 7. Materials related to the call will be available at that time through...

Nokia CorporationManagers’ transactions8 July 2025 at 16:00 EEST Nokia Corporation – Managers’ transactions (Heard) Transaction notification under Article 19 of EU Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Heard, DavidPosition: Other senior manager Issuer: Nokia CorporationLEI: 549300A0JPRWG1KI7U06Notification type: INITIAL NOTIFICATIONReference number: 115765/5/4____________________________________________ Transaction date: 2025-07-08Outside a trading venueInstrument type: SHAREISIN: FI0009000681Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 59430 Unit price: N/A Aggregated transactions(1): Volume: 59430 Volume weighted average price: N/A About NokiaAt Nokia, we create technology that helps the world...

Wix and MonotypeWix expands font library through strategic partnership with MonotypeThe new fonts empower self creators and agencies with a diverse range of high-quality typefaces NEW YORK – Wix.com Ltd. (NASDAQ: WIX), the leading SaaS website builder platform globally1, today announced a strategic partnership with Monotype Imaging Inc., a global leader in type design and technology, extending Wix’s font library. The newly curated typeface collection is now available to Wix users, self creators and agencies – offering them a broader spectrum of high-quality typefaces to elevate their content and match their vision, including greatest hits like Helvetica® and Avenir®, and a host of new classics such as Recoleta, Kibitz Pro, and Aether.  In consultation with type design experts at Monotype, Wix has carefully selected a diverse...

CALABASAS, Calif., July 08, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, today announced it has signed a non-binding term sheet with Quazar Investment to form a new UAE-based investment and clinical platform focused on the Middle East and North Africa (MENA) region. The non-binding term sheet outlines the formation of NuroMENA Holdings Ltd, a wholly owned holding company of NeOnc, which will oversee the incorporation of NuroCure, an Abu Dhabi onshore operating subsidiary. NuroCure will be responsible for initiating and managing clinical trials for NeOnc’s late-stage drug candidates, NEO100-01 NEO100-02 NEO100-03 pediatric drug and NEO212, across the UAE and the wider GCC and MENA...

PALO ALTO, CA, July 08, 2025 (GLOBE NEWSWIRE) — Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) an award-winning leader in AI Surveillance and Remote Guarding, announced today the company’s AI-driven security platform achieved an exceptional deterrence rate of over 98% of all threatening activity between January and May 2025—effectively preventing incidents of theft, trespassing, and confrontations before they could escalate into criminal acts. This performance highlights the strength of Cloudastructure’s platform at a time when property crime is rising nationwide and traditional security solutions are increasingly under pressure. During the first five months of 2025, the Company’s AI system generated 3.28 million alerts, including 929,019 in May alone. The platform also enabled 13,129...

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) — Satellogic, Inc. (NASDAQ: SATL), a leader in satellite manufacturing and high-resolution Earth observation data, today announced that it has been added as a member of the U.S. small-cap Russell 3000® Index, effective after market close on June 27, 2025 as part of the 2025 Russell indexes constitution. The Russell 3000® Index is a comprehensive, market-capitalization-weighted index that measures the performance of the 3,000 largest U.S. public companies. Membership in this widely recognized index means automatic inclusion in either the large-cap Russell 1000® Index or small-cap Russell 2000® Index, as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment...

PITTSBURGH, July 08, 2025 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today that it has entered into a standby equity purchase agreement (“SEPA”) with YA II PN, LTD, an investment fund managed by Yorkville Advisors Global, LP (“Yorkville”). Predictive Oncology expects the partnership to provide an efficient and flexible source of funding, enabling the company to progress its ongoing drug discovery, biomarker discovery and drug repurposing initiatives, and business development opportunities with leading biopharmaceutical companies, leveraging its novel AI and machine learning capabilities. Under the terms of the agreement, Predictive Oncology has the right to sell, and Yorkville has the obligation to purchase up to $10 million worth of the Company’s stock. Predictive...

Berberian brings significant technology leadership and cybersecurity expertise ARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. “We are excited to welcome Lance to our Board of Directors,” said David King, Chairman of the Board, Privia Health Group, Inc. “Lance brings extensive technology strategy and digital transformation experience to the Board, including IT governance, infrastructure management and cybersecurity. We believe his expertise will be invaluable to Privia Health as we continue to grow our business and build scaled provider networks...